![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TMEM209 |
Gene summary for TMEM209 |
![]() |
Gene information | Species | Human | Gene symbol | TMEM209 | Gene ID | 84928 |
Gene name | transmembrane protein 209 | |
Gene Alias | NET31 | |
Cytomap | 7q32.2 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | Q96SK2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
84928 | TMEM209 | LZE2T | Human | Esophagus | ESCC | 4.73e-03 | 2.96e-01 | 0.082 |
84928 | TMEM209 | LZE7T | Human | Esophagus | ESCC | 1.40e-08 | 3.23e-01 | 0.0667 |
84928 | TMEM209 | LZE20T | Human | Esophagus | ESCC | 1.26e-02 | 1.30e-01 | 0.0662 |
84928 | TMEM209 | LZE24T | Human | Esophagus | ESCC | 5.64e-10 | 2.14e-01 | 0.0596 |
84928 | TMEM209 | LZE6T | Human | Esophagus | ESCC | 2.96e-03 | 1.76e-01 | 0.0845 |
84928 | TMEM209 | P1T-E | Human | Esophagus | ESCC | 4.62e-03 | 1.73e-01 | 0.0875 |
84928 | TMEM209 | P2T-E | Human | Esophagus | ESCC | 7.40e-20 | 2.26e-01 | 0.1177 |
84928 | TMEM209 | P4T-E | Human | Esophagus | ESCC | 3.18e-14 | 2.86e-01 | 0.1323 |
84928 | TMEM209 | P5T-E | Human | Esophagus | ESCC | 1.66e-11 | 2.85e-01 | 0.1327 |
84928 | TMEM209 | P8T-E | Human | Esophagus | ESCC | 5.96e-07 | 2.01e-01 | 0.0889 |
84928 | TMEM209 | P9T-E | Human | Esophagus | ESCC | 8.38e-03 | 1.30e-01 | 0.1131 |
84928 | TMEM209 | P10T-E | Human | Esophagus | ESCC | 1.55e-11 | 2.68e-01 | 0.116 |
84928 | TMEM209 | P11T-E | Human | Esophagus | ESCC | 3.25e-05 | 1.81e-01 | 0.1426 |
84928 | TMEM209 | P12T-E | Human | Esophagus | ESCC | 9.64e-22 | 5.33e-01 | 0.1122 |
84928 | TMEM209 | P15T-E | Human | Esophagus | ESCC | 2.27e-23 | 4.37e-01 | 0.1149 |
84928 | TMEM209 | P16T-E | Human | Esophagus | ESCC | 8.40e-11 | 2.84e-01 | 0.1153 |
84928 | TMEM209 | P17T-E | Human | Esophagus | ESCC | 2.68e-03 | 1.62e-01 | 0.1278 |
84928 | TMEM209 | P20T-E | Human | Esophagus | ESCC | 2.86e-10 | 2.21e-01 | 0.1124 |
84928 | TMEM209 | P21T-E | Human | Esophagus | ESCC | 6.84e-23 | 4.64e-01 | 0.1617 |
84928 | TMEM209 | P22T-E | Human | Esophagus | ESCC | 9.21e-10 | 1.03e-01 | 0.1236 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Oral cavity | OSCC | ![]() |
Oral cavity | LP | ![]() |
Oral cavity | EOLP | ![]() |
Oral cavity | NEOLP | ![]() |
Esophagus | HGIN | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TMEM209 | SNV | Missense_Mutation | c.736N>T | p.Leu246Phe | p.L246F | Q96SK2 | protein_coding | deleterious(0.01) | probably_damaging(0.995) | TCGA-A8-A081-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TMEM209 | SNV | Missense_Mutation | c.424N>A | p.Tyr142Asn | p.Y142N | Q96SK2 | protein_coding | deleterious(0.02) | probably_damaging(0.929) | TCGA-C8-A1HJ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
TMEM209 | SNV | Missense_Mutation | c.1030N>G | p.Asn344Asp | p.N344D | Q96SK2 | protein_coding | tolerated(0.06) | benign(0.089) | TCGA-D8-A1XQ-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TMEM209 | SNV | Missense_Mutation | novel | c.1060N>C | p.Glu354Gln | p.E354Q | Q96SK2 | protein_coding | deleterious(0) | possibly_damaging(0.86) | TCGA-XX-A89A-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TMEM209 | deletion | Frame_Shift_Del | novel | c.13delN | p.Glu5ArgfsTer15 | p.E5Rfs*15 | Q96SK2 | protein_coding | TCGA-EW-A2FV-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | docetaxel | SD | ||
TMEM209 | SNV | Missense_Mutation | novel | c.1253C>A | p.Ser418Tyr | p.S418Y | Q96SK2 | protein_coding | deleterious(0) | possibly_damaging(0.452) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
TMEM209 | SNV | Missense_Mutation | c.1289N>A | p.Arg430Lys | p.R430K | Q96SK2 | protein_coding | tolerated(1) | benign(0.003) | TCGA-EA-A3QD-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Chemotherapy | cisplatin | CR | |
TMEM209 | SNV | Missense_Mutation | c.645N>C | p.Leu215Phe | p.L215F | Q96SK2 | protein_coding | tolerated(0.16) | possibly_damaging(0.875) | TCGA-EK-A2PG-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Unknown | Unknown | SD | |
TMEM209 | SNV | Missense_Mutation | c.1105N>C | p.Glu369Gln | p.E369Q | Q96SK2 | protein_coding | deleterious(0.01) | possibly_damaging(0.721) | TCGA-VS-A8EL-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
TMEM209 | SNV | Missense_Mutation | c.574N>G | p.Leu192Val | p.L192V | Q96SK2 | protein_coding | tolerated(0.51) | benign(0) | TCGA-AA-3510-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |